These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2907351)

  • 1. Pharmacological actions of synthetic atrial natriuretic factor on coronary vascular smooth muscle.
    Yanagisawa A; Lefer AM
    Jpn Circ J; 1988 Dec; 52(12):1436-40. PubMed ID: 2907351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vascular actions of synthetic atrial natriuretic factor in isolated vascular preparations.
    Yanagisawa A; Osborne JA; Stahl GL; Lefer AM
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):320-6. PubMed ID: 2444781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive effects of eicosapentaenoic acid on isolated vascular smooth muscle.
    Yanagisawa A; Lefer AM
    Basic Res Cardiol; 1987; 82(2):186-96. PubMed ID: 3038070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic factor in the Langendorff perfused coronary vasculature of the rabbit isolated heart.
    Klair SS; Louttit JB; Charlton PA
    Life Sci; 1989; 45(25):2477-83. PubMed ID: 2532696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
    Yanagisawa A; Smith JA; Brezinski ME; Lefer AM
    Eur J Pharmacol; 1987 Jan; 133(1):89-96. PubMed ID: 3030773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of coronary effects of atrial natriuretic factor in dogs.
    Ertl G; Bauer B; Gaudron P; Kolb M; Kochsiek K
    Eur J Clin Invest; 1992 Aug; 22(8):516-22. PubMed ID: 1425857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of relaxations to dendroaspis natriuretic peptide in canine coronary arteries.
    Collins E; Bracamonte MP; Burnett JC; Miller VM
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):614-8. PubMed ID: 10774793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the vasodilating activity of salbutamol on dog coronary arteries. Unexpected effects of methylene blue.
    Bernard F; Jouquey S; Hamon G
    Pharmacology; 1991; 42(5):246-51. PubMed ID: 1678890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary vascular and endothelial reactivity changes in transgenic mice overexpressing atrial natriuretic factor.
    Ku DD; Guo L; Dai J; Acuff CG; Steinhelper ME
    Am J Physiol; 1996 Dec; 271(6 Pt 2):H2368-76. PubMed ID: 8997295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle.
    Liang CF; Au AL; Leung SW; Ng KF; Félétou M; Kwan YW; Man RY; Vanhoutte PM
    J Pharmacol Exp Ther; 2010 Jul; 334(1):223-31. PubMed ID: 20332186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
    Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
    Winquist RJ; Faison EP; Waldman SA; Schwartz K; Murad F; Rapoport RM
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7661-4. PubMed ID: 6150486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries.
    Aalkjaer C; Mulvany MJ; Nyborg NC
    Br J Pharmacol; 1985 Oct; 86(2):447-53. PubMed ID: 2932194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic GMP as the mediator of molsidomine-induced vasodilatation.
    Kukovetz WR; Holzmann S
    Eur J Pharmacol; 1986 Mar; 122(1):103-9. PubMed ID: 3007172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of synthetic atrial natriuretic factor on contractility and coronary perfusion in isolated working rat hearts.
    Hütter JF
    Eur J Pharmacol; 1991 Jan; 193(1):127-9. PubMed ID: 1828766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
    Borg C; Mondot S; Mestre M; Cavero I
    J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biological activity of atrial natriuretic factor cleaved by endoprotease 3.4.24.11.
    Ghai RD; Webb RL; Sonnenberg JL; Sakane Y; Ghai G
    J Enzyme Inhib; 1991; 4(3):267-72. PubMed ID: 1645400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells.
    Wei CM; Hu S; Miller VM; Burnett JC
    Biochem Biophys Res Commun; 1994 Nov; 205(1):765-71. PubMed ID: 7999110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of nitrovasodilators and atrial natriuretic peptide in isolated dog coronary arteries.
    Matsumoto T; Okamura T; Kinoshita M; Toda N
    Eur J Pharmacol; 1993 Jun; 237(1):31-7. PubMed ID: 8395391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation and modulation of cyclic AMP production in response to atrial natriuretic peptides in guinea pig tracheal smooth muscle.
    Devillier P; Corompt E; Bréant D; Caron F; Bessard G
    Eur J Pharmacol; 2001 Nov; 430(2-3):325-33. PubMed ID: 11711051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.